Kellie J Ryan
Overview
Explore the profile of Kellie J Ryan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel H, Wahlstrom S, DerSarkissian M, Kunzweiler C, Castriota F, Chang R, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2023 Apr;
23(6):651-658.
PMID: 37021518
Objectives: Novel therapies improve clinical outcomes in chronic lymphocytic leukemia (CLL), although adverse event (AE) profiles differ. This study evaluated time and personnel costs of AE management among healthcare professionals...
2.
Engel-Nitz N, Johnson M, Bunner S, Ryan K
J Manag Care Spec Pharm
. 2020 May;
26(6):729-740.
PMID: 32463768
Background: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer in the United States. Immunotherapies and cytotoxic chemotherapies used to treat advanced NSCLC carry a substantial...
3.
Ryan K, Nero D, Feinberg B, Lee C, Pimentel R, Gajra A, et al.
Future Oncol
. 2019 Dec;
16(1):4303-4313.
PMID: 31802700
To estimate the real-world incidence and timing of radiation pneumonitis following chemoradiotherapy for Stage III non-small-cell lung cancer and compare costs between patients with and without radiation pneumonitis. Retrospective analysis...
4.
Ryan K, Skinner K, Fernandes A, Punekar R, Pavilack M, Walker M, et al.
Future Oncol
. 2019 May;
15(25):2943-2953.
PMID: 31037966
Little is known about recent treatment patterns among patients with unresected stage III NSCLC in the real world. This retrospective study used medical records from USA community oncology practices to...
5.
Ryan K, Skinner K, Fernandes A, Punekar R, Pavilack M, Walker M, et al.
Med Oncol
. 2019 Feb;
36(3):24.
PMID: 30706218
This study examined real-world clinical outcomes such as progression-free survival (PFS), time to metastasis (TTM), overall survival (OS), and health-related quality of life (HRQOL) in patients with unresected stage III...
6.
Offutt S, Ryan K, Konop A, Lim H
J Neural Eng
. 2014 Oct;
11(6):066001.
PMID: 25307351
Objective: The inferior colliculus (IC) is the primary processing center of auditory information in the midbrain and is one site of tinnitus-related activity. One potential option for suppressing the tinnitus...
7.
Stewart D, Ryan K, Seare J, Pinsky B, Becker L, Frogel M
BMC Infect Dis
. 2013 Jul;
13:334.
PMID: 23870086
Background: Palivizumab has been shown to decrease the incidence of hospitalization due to respiratory syncytial virus (RSV) in infants at risk of severe RSV disease. We examined the association between...
8.
Glezen W, Schmier J, Kuehn C, Ryan K, Oxford J
Am J Public Health
. 2013 Jan;
103(3):e43-51.
PMID: 23327249
We reviewed the epidemiology, clinical characteristics, disease severity, and economic burden of influenza B as reported in the peer-reviewed published literature. We used MEDLINE to perform a systematic literature review...
9.
Flood E, Ryan K, Rousculp M, Beusterien K, Block S, Hall M, et al.
Vaccine
. 2011 Apr;
29(26):4334-40.
PMID: 21510993
Background: While annual influenza vaccination is recommended by the CDC for children 6 months and older, vaccination rates remain suboptimal. For healthy, US children 2 years of age and older,...
10.
Flood E, Ryan K, Rousculp M, Beusterien K, Divino V, Block S, et al.
Clin Pediatr (Phila)
. 2011 Jan;
50(4):338-47.
PMID: 21196417
Influenza vaccine is available as an intramuscular injection or an intranasal spray for eligible children. This study was conducted to examine parents' preferences for influenza vaccine attributes and the attributes'...